{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-035687","form_type":"8-K","ticker":"SYRA","cik":"0001922335","company_name":"Syra Health Corp","filed_at":"2023-10-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.403911+00:00","generated_at":"2026-06-10T05:02:37.660972+00:00","sec_items":["5.02","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Syra Health prices upsized IPO of 1.615M units at $4.125/unit, raises ~$6.7M gross","bullets":["IPO units priced at $4.125 each: one share Class A common + one warrant (exercise $6.50, 5-year term).","Gross proceeds of approx. $6.7 million before underwriting discounts and expenses.","Shares began trading on Nasdaq on Sept 29 under ticker SYRA; IPO closed Oct 3, 2023.","Underwriters partially exercised over-allotment for 242,250 warrants at $0.01 each; option remains for 242,250 additional shares.","Five new independent directors appointed effective Oct 3: Rogers, Dahlem, V. Reddy, Paranjape, A. Reddy; committee chairs named."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-035687","json":"https://secwatch.observer/filing/0001493152-23-035687.json","markdown":"https://secwatch.observer/filing/0001493152-23-035687.md","text":"https://secwatch.observer/filing/0001493152-23-035687.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1922335/000149315223035687/0001493152-23-035687-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1922335/000149315223035687/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T05:02:37.660972+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6453a30865","claim":"Andrew Dahlem was appointed as Director at Syra Health Corp.","evidence_excerpt":"Effective as of October 3, 2023, each of Sherron Rogers, Andrew Dahlem, Vijayapal Reddy, Ketan Paranjape, and Avutu Reddy were appointed to serve as members of Syra Health Corp.'s (the “Company’s”) board of directors (the “Board”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1922335/000149315223035687/0001493152-23-035687-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"830348ea37","claim":"Vijayapal Reddy was appointed as Director at Syra Health Corp.","evidence_excerpt":"Effective as of October 3, 2023, each of Sherron Rogers, Andrew Dahlem, Vijayapal Reddy, Ketan Paranjape, and Avutu Reddy were appointed to serve as members of Syra Health Corp.'s (the “Company’s”) board of directors (the “Board”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1922335/000149315223035687/0001493152-23-035687-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"aa942f4c80","claim":"Avutu Reddy was appointed as Director at Syra Health Corp.","evidence_excerpt":"Effective as of October 3, 2023, each of Sherron Rogers, Andrew Dahlem, Vijayapal Reddy, Ketan Paranjape, and Avutu Reddy were appointed to serve as members of Syra Health Corp.'s (the “Company’s”) board of directors (the “Board”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1922335/000149315223035687/0001493152-23-035687-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"d1c136352a","claim":"Sherron Rogers was appointed as Director at Syra Health Corp.","evidence_excerpt":"Effective as of October 3, 2023, each of Sherron Rogers, Andrew Dahlem, Vijayapal Reddy, Ketan Paranjape, and Avutu Reddy were appointed to serve as members of Syra Health Corp.'s (the “Company’s”) board of directors (the “Board”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1922335/000149315223035687/0001493152-23-035687-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"dd502fea75","claim":"Ketan Paranjape was appointed as Director at Syra Health Corp.","evidence_excerpt":"Effective as of October 3, 2023, each of Sherron Rogers, Andrew Dahlem, Vijayapal Reddy, Ketan Paranjape, and Avutu Reddy were appointed to serve as members of Syra Health Corp.'s (the “Company’s”) board of directors (the “Board”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1922335/000149315223035687/0001493152-23-035687-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}